rs762176717
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001036.6(RYR3):āc.4991G>Cā(p.Gly1664Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000582 in 1,614,020 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Consequence
NM_001036.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RYR3 | NM_001036.6 | c.4991G>C | p.Gly1664Ala | missense_variant | 35/104 | ENST00000634891.2 | NP_001027.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RYR3 | ENST00000634891.2 | c.4991G>C | p.Gly1664Ala | missense_variant | 35/104 | 1 | NM_001036.6 | ENSP00000489262 | P4 | |
RYR3 | ENST00000389232.9 | c.4991G>C | p.Gly1664Ala | missense_variant | 35/104 | 5 | ENSP00000373884 | A1 | ||
RYR3 | ENST00000415757.7 | c.4991G>C | p.Gly1664Ala | missense_variant | 35/103 | 2 | ENSP00000399610 | A2 | ||
RYR3 | ENST00000634418.1 | c.4991G>C | p.Gly1664Ala | missense_variant | 35/102 | 5 | ENSP00000489529 |
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152190Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000481 AC: 12AN: 249270Hom.: 0 AF XY: 0.0000666 AC XY: 9AN XY: 135234
GnomAD4 exome AF: 0.0000575 AC: 84AN: 1461712Hom.: 1 Cov.: 36 AF XY: 0.0000550 AC XY: 40AN XY: 727138
GnomAD4 genome AF: 0.0000657 AC: 10AN: 152308Hom.: 0 Cov.: 32 AF XY: 0.0000671 AC XY: 5AN XY: 74478
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 17, 2014 | The c.4991G>C (p.G1664A) alteration is located in exon 35 (coding exon 35) of the RYR3 gene. This alteration results from a G to C substitution at nucleotide position 4991, causing the glycine (G) at amino acid position 1664 to be replaced by an alanine (A). The alteration is not observed in healthy cohorts: Based on data from the NHLBI Exome Sequencing Project (ESP), the RYR3 c.4991G>C alteration was not observed among 6,093 individuals tested. Allele frequency data for this nucleotide position are not currently available from the 1000 Genomes Project and the alteration is not currently listed in the Database of Single Nucleotide Polymorphisms (dbSNP). Though some variants may appear to be rare due to database-specific ethnic underrepresentation, rare missense alleles commonly exhibit a deleterious effect on protein function (Kryukov, 2007; Tennessen, 2012). IF USED, PULL THESE INTO REFERENCES: Kryukov GV, et al. (2007) Am J Hum Genet 80:727-739. Tennessen JA, et al. (2012) Science 337(64):64-69. The altered amino acid is not conserved throughout evolution: The p.G1664 amino acid position is poorly conserved in available vertebrate species. The alteration is predicted benign by in silico models: The p.G1664A alteration is predicted to be benign by Polyphen and tolerated by SIFT in silico analyses. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Epileptic encephalopathy Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 08, 2021 | This sequence change replaces glycine with alanine at codon 1664 of the RYR3 protein (p.Gly1664Ala). The glycine residue is moderately conserved and there is a small physicochemical difference between glycine and alanine. This variant is present in population databases (rs762176717, ExAC 0.007%). This variant has not been reported in the literature in individuals affected with RYR3-related conditions. ClinVar contains an entry for this variant (Variation ID: 224984). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at